metformin has been researched along with ergothioneine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Futatsugi, A; Kato, Y; Kawabata, S; Masuo, Y; Nakamichi, N | 1 |
Channa, ML; Dare, A; Nadar, A | 2 |
3 other study(ies) available for metformin and ergothioneine
Article | Year |
---|---|
L503F variant of carnitine/organic cation transporter 1 efficiently transports metformin and other biguanides.
Topics: Amines; Asian People; Biguanides; Biological Transport, Active; Buformin; Carnitine; Cyclohexanecarboxylic Acids; Ergothioneine; Gabapentin; gamma-Aminobutyric Acid; HEK293 Cells; Humans; Intestinal Absorption; Metformin; Organic Cation Transporter 1; Polymorphism, Single Nucleotide; White People | 2016 |
L-ergothioneine and its combination with metformin attenuates renal dysfunction in type-2 diabetic rat model by activating Nrf2 antioxidant pathway.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Ergothioneine; Hypoglycemic Agents; Kidney; Male; Metformin; NF-E2-Related Factor 2; Rats; Rats, Sprague-Dawley; Signal Transduction | 2021 |
L-ergothioneine and metformin alleviates liver injury in experimental type-2 diabetic rats via reduction of oxidative stress, inflammation, and hypertriglyceridemia.
Topics: Administration, Oral; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Ergothioneine; Hypertriglyceridemia; Inflammation; Insulin Resistance; Liver Diseases; Male; Metformin; Oxidative Stress; Rats, Sprague-Dawley | 2021 |